INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 109 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $336,000 | -6.9% | 112,100 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $361,000 | +455.4% | 111,700 | +265.6% | 0.00% | +300.0% |
| Q4 2020 | $65,000 | +80.6% | 30,551 | 0.0% | 0.00% | – |
| Q3 2020 | $36,000 | -73.7% | 30,551 | -79.7% | 0.00% | -100.0% |
| Q2 2020 | $137,000 | +7.9% | 150,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $127,000 | -20.1% | 150,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $159,000 | 0.0% | 150,500 | -2.0% | 0.00% | 0.0% |
| Q3 2019 | $159,000 | -42.6% | 153,550 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $277,000 | -6.4% | 153,550 | -2.3% | 0.00% | 0.0% |
| Q1 2019 | $296,000 | +59.1% | 157,150 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $186,000 | -56.8% | 157,150 | -1.1% | 0.00% | -50.0% |
| Q3 2018 | $431,000 | +41.8% | 158,907 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $304,000 | -8.7% | 158,907 | +0.1% | 0.00% | 0.0% |
| Q1 2018 | $333,000 | -5.1% | 158,775 | -8.1% | 0.00% | 0.0% |
| Q4 2017 | $351,000 | +44.4% | 172,780 | -5.3% | 0.00% | +50.0% |
| Q3 2017 | $243,000 | -15.0% | 182,380 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $286,000 | -51.4% | 182,380 | 0.0% | 0.00% | -60.0% |
| Q1 2017 | $589,000 | +139.4% | 182,380 | 0.0% | 0.01% | +150.0% |
| Q4 2016 | $246,000 | -13.7% | 182,380 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $285,000 | +17.3% | 182,380 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $243,000 | -74.7% | 182,380 | 0.0% | 0.00% | -77.8% |
| Q1 2016 | $961,000 | -32.9% | 182,380 | 0.0% | 0.01% | -35.7% |
| Q4 2015 | $1,432,000 | -7.1% | 182,380 | 0.0% | 0.01% | -12.5% |
| Q3 2015 | $1,541,000 | -22.8% | 182,380 | 0.0% | 0.02% | -36.0% |
| Q2 2015 | $1,997,000 | -21.7% | 182,380 | 0.0% | 0.02% | -13.8% |
| Q1 2015 | $2,549,000 | +92.8% | 182,380 | +133.1% | 0.03% | +93.3% |
| Q4 2014 | $1,322,000 | – | 78,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |